BREZTRI 160 ug/1

BREZTRI 160 ug/1 is a combination inhaler containing budesonide, glycopyrrolate, and formoterol fumarate. It is used for respiratory conditions like asthma and COPD. This metered aerosol inhaler provides targeted relief for breathing difficulties.

BREZTRI 160 ug/1 is primarily used for managing respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The combination of budesonide, glycopyrrolate, and formoterol fumarate works to reduce inflammation, relax airway muscles, and improve breathing. This inhaler is often prescribed for individuals who require multiple medications to control their symptoms effectively.

Common effects of using BREZTRI 160 ug/1 may include improved breathing and reduced wheezing. Some users might experience mild side effects such as throat irritation or a dry mouth. It is important to follow the prescribed usage to minimize potential discomfort.

When using BREZTRI 160 ug/1, it is crucial to follow the instructions provided by your healthcare professional. Always use the inhaler as directed and store it properly to maintain its effectiveness. Avoid exposure to extreme temperatures and keep the inhaler out of reach of children.

BREZTRI 160 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, avoid using alcohol or other respiratory medications without consulting your doctor.